Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

SKB reports neuronal calcium channel antagonists

April 29, 1997

Sanofi describes selective NK3 receptor antagonists

April 29, 1997

Delta-opioid agonists/antagonists described by SmithKline Beecham

April 29, 1997

Parke-Davis SAR studies lead to potent, selective D4 antagonist

April 28, 1997

Discovery of potent and selective mu-opiate receptor agonists

April 28, 1997

Mimetix initiates clinical trial with injectable form of naproxen

April 25, 1997

CoCensys discovers potent, water-soluble allosteric modulators of GABA-A receptor

April 25, 1997

Neurotrophic/neuroprotective agents described by Synthelabo

April 25, 1997

Clinical results from international comparative study of olanzapine and haloperidol

April 24, 1997

Eletriptan enters phase III trials

April 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...